Credential Qtrade Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $858K | Buy |
9,827
+167
| +2% | +$14.6K | 0.05% | 162 |
|
|
2023
Q4 | $931K | Sell |
9,660
-487
| -5% | -$47K | 0.06% | 138 |
|
|
2023
Q3 | $898K | Buy |
10,147
+47
| +0.5% | +$4.16K | 0.06% | 137 |
|
|
2023
Q2 | $875K | Buy |
10,100
+2,682
| +36% | +$232K | 0.06% | 143 |
|
|
2023
Q1 | $721K | Buy |
7,418
+3,403
| +85% | +$331K | 0.05% | 155 |
|
|
2022
Q4 | $416K | Sell |
4,015
-52
| -1% | -$5.38K | 0.03% | 197 |
|
|
2022
Q3 | $345K | Buy |
4,067
+143
| +4% | +$12.1K | 0.03% | 191 |
|
|
2022
Q2 | $325K | Sell |
3,924
-2,715
| -41% | -$225K | 0.02% | 202 |
|
|
2022
Q1 | $512K | Buy |
6,639
+341
| +5% | +$26.3K | 0.03% | 182 |
|
|
2021
Q4 | $556K | Buy |
6,298
+86
| +1% | +$7.6K | 0.04% | 182 |
|
|
2021
Q3 | $480K | Buy |
6,212
+331
| +6% | +$25.6K | 0.04% | 179 |
|
|
2021
Q2 | $491K | Buy |
5,881
+775
| +15% | +$64.7K | 0.04% | 174 |
|
|
2021
Q1 | $386K | Buy |
5,106
+2,349
| +85% | +$177K | 0.03% | 185 |
|
|
2020
Q4 | $242K | Hold |
2,757
| – | – | 0.03% | 185 |
|
|
2020
Q3 | $210K | Buy |
2,757
+1,761
| +177% | +$134K | 0.02% | 189 |
|
|
2020
Q2 | $123K | Buy |
996
+127
| +15% | +$15.7K | 0.02% | 201 |
|
|
2020
Q1 | $73.4K | Sell |
869
-1,065
| -55% | -$90K | 0.01% | 194 |
|
|
2019
Q4 | $164K | Buy |
1,934
+637
| +49% | +$53.9K | 0.02% | 170 |
|
|
2019
Q3 | $87.4K | Buy |
1,297
+21
| +2% | +$1.42K | 0.01% | 187 |
|
|
2019
Q2 | $109K | Sell |
1,276
-1,102
| -46% | -$94.4K | 0.02% | 185 |
|
|
2019
Q1 | $211K | Sell |
2,378
-79
| -3% | -$7.02K | 0.04% | 157 |
|
|
2018
Q4 | $209K | Buy |
2,457
+590
| +32% | +$50.3K | 0.05% | 148 |
|
|
2018
Q3 | $181K | Buy |
+1,867
| New | +$181K | 0.04% | 169 |
|